Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Immunological Reviews|February 1, 2022
T peripheral helper cells in autoimmune diseasesKathryne E Marks, Deepak A Rao
STAR Protocols|January 5, 2025
Protocol for assessing T cell receptor-mediated human T cell cytotoxicityKathryne E Marks, Ifeoluwakiisi Adejoorin, John Sowerby, et al.
Immune Network|July 19, 2021
Toll-like Receptor 2 in Autoimmune InflammationKathryne E Marks, Kaylin Cho, Courtney Stickling, et al.
Seminars in Arthritis and Rheumatism|November 19, 2024
Defining immune cell phenotypes that distinguish treatment responders and non-responders in RAKathryne E Marks, Alice Horisberger, Daniel H Solomon, et al.
Cell Reports|June 30, 2021
Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role for IPCEF in regulating Th17 cell migrationKathryne E Marks, Stephanie Flaherty, Kristen M Patterson, et al.
ACR Open Rheumatology|September 18, 2021
Importance of Shared Treatment Goal Discussions in Rheumatoid Arthritis-A Cross-Sectional Survey: Patients Report Providers Seldom Discuss Treatment Goals and Outcomes Improve When Goals Are DiscussedKelly D O'Neill, Kathryne E Marks, Pamela S Sinicrope, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Pre-treatment naïve T cells are associated with severe irAE following PD-1/CTLA4 checkpoint blockade for melanomaKathryne E Marks, Alice Horisberger, Mehreen Elahee, et al.
JCI Insight|November 26, 2025
Pre-treatment naïve T cells are associated with severe irAE following PD-1/CTLA4 checkpoint blockade for melanomaKathryne E Marks, Alice Horisberger, Mehreen Elahee, et al.
ACR Open Rheumatology|May 3, 2024
A PD-1<sup>high</sup>CD4<sup>+</sup> T Cell Population With a Cytotoxic Phenotype is Associated With Interstitial Lung Disease in Systemic SclerosisMehreen Elahee, Alisa A Mueller, Runci Wang, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Single Cell Analysis of pBMCs of Psoriasis patients reveals distinct CD4+ T cell phenotypes associated with response to IL-23 blockadeKathryne E Marks, Anina Sun, Ifeoluwakiisi Adejoorin, et al.
Pageof 2